Andrea Luppi
Wellcome Research Fellow at the Cambridge Centre for Physical Biology, University of Cambridge
Data updated
Research Footprint
Andrea Luppi appears in 8 tracked papers (2021–2025), most studied alongside LSD, Ketamine and Psilocybin, across Neuroimaging & Brain Measures, Substance Use Disorders (SUD) and Neurological Injury.
Most-cited paper: LSD alters dynamic integration and segregation in the human brain (185 citations).
Frequent co-authors: Robin Carhart-Harris, Leor Roseman and Morten Kringelbach.
Background & Research
Andrea I. Luppi is a neuroscientist at the University of Cambridge whose work focuses on the relationship between brain structure, dynamics, and consciousness. His research has explored how psychedelics and other perturbations alter functional brain organization, including connectome harmonics, turbulent brain dynamics, and structure-function coupling. He is listed as a Wellcome Research Fellow at the Cambridge Centre for Physical Biology and is affiliated with the University of Cambridge's neuroscience community.
Key Impact
Andrea Luppi is notable for applying connectome harmonic decomposition and network neuroscience to altered states of consciousness, including psychedelics such as LSD, DMT, and psilocybin.
Collaboration Network
18 collaborators· click a node to visit their profile
Full network →Compounds
Topics
Top Collaborators
Affiliations
Institutions, companies, and organisations Andrea Luppi is associated with.
University of Cambridge
academicThe Cambridge Psychedelic Research Group (CPRG) brings together scientists, psychiatrists, and clinical psychologists to rigorously advance psychedelic-assisted therapy for mental health. The CPRG initiated its first clinical trials focusing on psychedelic-assisted therapy for post-traumatic stress disorder (PTSD). Currently, the center is initiating additional trials to investigate the therapeutic potential of psilocybin for adults suffering from treatment-resistant depression and generalized anxiety disorder.
View stakeholder →Imperial College London
academicThe Centre for Psychedelic Research, led by Professor David Nutt and Dr. David Erritzoe, focuses heavily on the action of psychedelic drugs in the brain and their clinical utility as aides to psychotherapy. Thanks to their extensive neuroimaging studies, this group has proposed vital mechanisms for how psychedelics work, including the Entropic Brain Theory and REBUS (RElaxed Beliefs Under Psychedelics).
View stakeholder →